COPD: Cipla launches Spirofy, Health News, ET HealthWorld

2021-11-18 08:00:46 By : Ms. Zora Zheng

We have updated our terms and conditions and privacy policy. Click "Continue" to accept and continue to use ET HealthWorld

Dear users, ET HealthWorld's privacy and cookie policy has been updated to comply with the EU's new data regulations. Please review and accept these changes below to continue using the site. You can check our privacy policy and our cookie policy. We use cookies to ensure you get the best experience on our website. If you choose to ignore this message, we will assume that you are happy to receive all cookies on ET HealthWorld.

India has reported 11,919 new Covid cases, and more than 33 million people discharged from hospital 3 hours ago

Officials said 7 hours ago that the number of deaths from drug overdose in the United States exceeded 100,000 in a year

Unsung heroes with faster overall recovery

Technological disruption in the health and pharmaceutical sectors in India

Do you think you are ready for the challenge?

A total solution for a healthier India

At present, COPD is still the second most common cause of death in India after heart disease. India alone bears 32% of the global burden of COPD.

125,000 industry leaders read every day

Countries with the highest vaccination coverage are stockpiling more vaccines, and low-income countries are even struggling to obtain the first dose of vaccine for their populations.

Countries with the highest vaccination coverage are stockpiling more vaccines, and low-income countries are even struggling to obtain the first dose of vaccine for their populations.

We have a variety of advertising options, including events, advertisements, banners, emails, webinars, etc.

Please contact us for more details.

Get ETHealthworld headlines in your email inbox every morning.

125,000 industry leaders read every day

Follow @ETHealthworld for the latest news, internal visits, etc.